Treatment therapy dose/schedule
. | Full-intensity therapy dose/schedule . | Reduced-intensity therapy dose/schedule . |
---|---|---|
COP | Cyclophosphamide 300 mg/m2 day 1 | Same |
Vincristine 1.0 mg/m2 day 1 | ||
Prednisone 60 mg/m2 (divided doses) days 1-7 | ||
IT MTX 8-15 mg/m2 day 1,3,5 | ||
IT hydrocortisone 8-15 mg/m2 days 1,3,5 | ||
IT cytarabine 15-30 mg/m2 days 1,3,5 | ||
COPADM 1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
Cyclophosphamide 250 mg/m2 every 12 h days 2-4 | ||
Doxorubicin 60 mg/m2 day 2 | ||
IT MTX 8-15 mg/m2 days 1,3,5 | ||
IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
COPADM 2 | Vincristine 2.0 mg/m2 d 1 (maximum: 2.0 mg) | Same |
Prednisone 60 mg/m2 (divided doses) d 1-5 then reduce over 3 d to 0 | ||
HDMTX 8000 mg/m2 d 1 in 4-h infusion + rescue | ||
Cyclophosphamide 500 mg/m2 every 12 h d 2-4 | ||
Doxorubicin 60 mg/m2 day 2 | ||
IT MTX 8-15 mg/m2 days 1,3,5 | ||
IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
CNS− | HD Ara-C 3000 mg/m2 days 2-5 | |
Etoposide 200 mg/m2 days 2-5 | ||
CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
CNS+ | HD Ara-C 3000 mg/m2 days 2-5 | |
Etoposide 200 mg/m2 days 2-5 | ||
IT MTX and hydrocortisone 8-15 mg/m2 day 1 | ||
HDMTX 8000 mg/m2 day 18* | ||
IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19* | ||
Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
CNS− | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
Etoposide 100 mg/m2 days 2-5 | ||
Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
CNS+ | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
Etoposide 100 mg/m2 days 2-5 | ||
HDMTX 8000 mg/m2 day 18† in 4-h infusion + rescue | ||
IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19† | ||
M1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
Cyclophosphamide 500 mg/m2 every 12 h days 2,3 | ||
HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
Doxorubicin 60 mg/m2 day 2 | ||
IT MTX 8-15 mg/m2 day 2 | ||
IT hydrocortisone 8-15 mg/m2 day 2 | ||
IT cytarabine 15-30 mg/m2 day 2 | ||
M2 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
Etoposide 150 mg/m2 days 1-3 | ||
M3 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Deleted |
Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
Cyclophosphamide mg/m2 days 1-2 | ||
Doxorubicin 60 mg/m2 day 1 | ||
M4 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
Etoposide 150 mg/m2 days 1-3 |
. | Full-intensity therapy dose/schedule . | Reduced-intensity therapy dose/schedule . |
---|---|---|
COP | Cyclophosphamide 300 mg/m2 day 1 | Same |
Vincristine 1.0 mg/m2 day 1 | ||
Prednisone 60 mg/m2 (divided doses) days 1-7 | ||
IT MTX 8-15 mg/m2 day 1,3,5 | ||
IT hydrocortisone 8-15 mg/m2 days 1,3,5 | ||
IT cytarabine 15-30 mg/m2 days 1,3,5 | ||
COPADM 1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
Cyclophosphamide 250 mg/m2 every 12 h days 2-4 | ||
Doxorubicin 60 mg/m2 day 2 | ||
IT MTX 8-15 mg/m2 days 1,3,5 | ||
IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
COPADM 2 | Vincristine 2.0 mg/m2 d 1 (maximum: 2.0 mg) | Same |
Prednisone 60 mg/m2 (divided doses) d 1-5 then reduce over 3 d to 0 | ||
HDMTX 8000 mg/m2 d 1 in 4-h infusion + rescue | ||
Cyclophosphamide 500 mg/m2 every 12 h d 2-4 | ||
Doxorubicin 60 mg/m2 day 2 | ||
IT MTX 8-15 mg/m2 days 1,3,5 | ||
IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
CNS− | HD Ara-C 3000 mg/m2 days 2-5 | |
Etoposide 200 mg/m2 days 2-5 | ||
CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
CNS+ | HD Ara-C 3000 mg/m2 days 2-5 | |
Etoposide 200 mg/m2 days 2-5 | ||
IT MTX and hydrocortisone 8-15 mg/m2 day 1 | ||
HDMTX 8000 mg/m2 day 18* | ||
IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19* | ||
Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
CNS− | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
Etoposide 100 mg/m2 days 2-5 | ||
Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
CNS+ | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
Etoposide 100 mg/m2 days 2-5 | ||
HDMTX 8000 mg/m2 day 18† in 4-h infusion + rescue | ||
IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19† | ||
M1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
Cyclophosphamide 500 mg/m2 every 12 h days 2,3 | ||
HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
Doxorubicin 60 mg/m2 day 2 | ||
IT MTX 8-15 mg/m2 day 2 | ||
IT hydrocortisone 8-15 mg/m2 day 2 | ||
IT cytarabine 15-30 mg/m2 day 2 | ||
M2 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
Etoposide 150 mg/m2 days 1-3 | ||
M3 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Deleted |
Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
Cyclophosphamide mg/m2 days 1-2 | ||
Doxorubicin 60 mg/m2 day 1 | ||
M4 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
Etoposide 150 mg/m2 days 1-3 |